
Berry Genomics Co.,Ltd — Investor Relations & Filings
Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2023年第三次临时股东大会决议公告 | 2023-08-04 | Chinese | |
| 第十届监事会第一次会议决议公告 | 2023-08-04 | Chinese | |
| 北京市金杜律师事务所关于成都市贝瑞和康基因技术股份有限公司2023年第三次临时股东大会之法律意见书 | 2023-08-04 | Chinese | |
| 独立董事关于第十届董事会第一次会议相关事项的独立意见 | 2023-08-04 | Chinese | |
| 关于选举第十届监事会职工代表监事的公告 | 2023-08-04 | Chinese | |
| 独立董事提名人声明-张大可 | 2023-07-18 | Chinese |
Browse filings by year
27 years- 2026 23 filings
- 2025 83 filings
- 2024 89 filings
- 2023 127 filings
- 2022 106 filings
- 2021 125 filings
- 2020 162 filings
- 2019 112 filings
- 2018 131 filings
- 2017 154 filings
- 2016 161 filings
- 2015 76 filings
- 2014 146 filings
- 2013 52 filings
- 2012 68 filings
- 2011 33 filings
- 2010 44 filings
- 2009 45 filings
- 2008 34 filings
- 2007 52 filings
- 2006 59 filings
- 2005 39 filings
- 2004 18 filings
- 2003 34 filings
- 2002 29 filings
- 2001 5 filings
- 1997 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 43271003 | 2023年第三次临时股东大会决议公告 | 2023-08-04 | Chinese | ||
| 43270965 | 第十届监事会第一次会议决议公告 | 2023-08-04 | Chinese | ||
| 43270937 | 北京市金杜律师事务所关于成都市贝瑞和康基因技术股份有限公司2023年第三次临时股东大会之法律意见书 | 2023-08-04 | Chinese | ||
| 43270902 | 独立董事关于第十届董事会第一次会议相关事项的独立意见 | 2023-08-04 | Chinese | ||
| 43270867 | 关于选举第十届监事会职工代表监事的公告 | 2023-08-04 | Chinese | ||
| 43270825 | 独立董事提名人声明-张大可 | 2023-07-18 | Chinese | ||
| 43270803 | 关联方资金往来管理制度 | 2023-07-18 | Chinese | ||
| 43270770 | 对外投资管理制度 | 2023-07-18 | Chinese | ||
| 43270731 | 股东大会议事规则 | 2023-07-18 | Chinese | ||
| 43270691 | 募集资金管理制度 | 2023-07-18 | Chinese | ||
| 43270658 | 独立董事年报工作制度 | 2023-07-18 | Chinese | ||
| 43270625 | 董事会战略委员会工作细则 | 2023-07-18 | Chinese | ||
| 43270599 | 独立董事候选人关于参加独立董事培训并取得独立董事资格证书的承诺函(胡诗阳) | 2023-07-18 | Chinese | ||
| 43270573 | 关于召开2023年第三次临时股东大会的通知 | 2023-07-18 | Chinese | ||
| 43270533 | 独立董事候选人声明-张大可 | 2023-07-18 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Berry Genomics Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53769/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53769 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53769 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53769 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53769}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Berry Genomics Co.,Ltd (id: 53769)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.